
June 10, 2015 – Study in PLOS ONE finds up to a 21% increased risk of heart attack associated with PPI use compared to H2 blockers (Pepcid, Tagamet, Zantac).
June 10, 2015 – Study in PLOS ONE finds up to a 21% increased risk of heart attack associated with PPI use compared to H2 blockers (Pepcid, Tagamet, Zantac).